Lived experiences of female patients aged 15-49 years undergoing treatment for multi-drug resistant tuberculosis (MDR-TB) in Lira Regional Referral Hospital, Uganda

Kizito Omona, Christopher Ogwang
{"title":"Lived experiences of female patients aged 15-49 years undergoing treatment for multi-drug resistant tuberculosis (MDR-TB) in Lira Regional Referral Hospital, Uganda","authors":"Kizito Omona, Christopher Ogwang","doi":"10.1080/27707571.2023.2292892","DOIUrl":null,"url":null,"abstract":": Multidrug-resistant tuberculosis (MDR-TB) is a major public health hazard on a global scale. It is a kind of tuberculosis (TB) infection produced by bacteria resistant to at least two of the most effective first-line anti-tuberculosis (anti-TB) drugs: isoniazid and rifampicin. In numerous health care facilities around Uganda, MDR-TB patients have bad experiences. The purpose of this study was to investigate the lived experiences of female patients aged 15 to 49 years receiving treatment for MDR-TB at Lira Regional Referral Hospital, Uganda. Using a method of purposive sampling, a phenomenological qualitative study was done among female patients aged 15 to 49 receiving treatment for multidrug-resistant tuberculosis at Lira Regional Hospital. Data was collected using an English-translated Lango guide for in-depth interviews. Data was entered manually and analyzed using version 13 of the qualitative program NVIVO. It was discovered that the spouses of female MDR-TB patients lacked social support. Female patients with a history of tuberculosis prior to MDR-TB had","PeriodicalId":224626,"journal":{"name":"Cogent Public Health","volume":" 19","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cogent Public Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/27707571.2023.2292892","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

: Multidrug-resistant tuberculosis (MDR-TB) is a major public health hazard on a global scale. It is a kind of tuberculosis (TB) infection produced by bacteria resistant to at least two of the most effective first-line anti-tuberculosis (anti-TB) drugs: isoniazid and rifampicin. In numerous health care facilities around Uganda, MDR-TB patients have bad experiences. The purpose of this study was to investigate the lived experiences of female patients aged 15 to 49 years receiving treatment for MDR-TB at Lira Regional Referral Hospital, Uganda. Using a method of purposive sampling, a phenomenological qualitative study was done among female patients aged 15 to 49 receiving treatment for multidrug-resistant tuberculosis at Lira Regional Hospital. Data was collected using an English-translated Lango guide for in-depth interviews. Data was entered manually and analyzed using version 13 of the qualitative program NVIVO. It was discovered that the spouses of female MDR-TB patients lacked social support. Female patients with a history of tuberculosis prior to MDR-TB had
乌干达利拉地区转诊医院 15-49 岁接受耐多药结核病(MDR-TB)治疗的女性患者的生活经历
:耐多药结核病(MDR-TB)是全球范围内严重危害公共健康的疾病。它是一种由对至少两种最有效的一线抗结核(抗结核)药物--异烟肼和利福平--产生耐药性的细菌引起的结核病(TB)感染。在乌干达各地的许多医疗机构中,MDR-TB 患者都有不愉快的经历。本研究旨在调查在乌干达利拉地区转诊医院接受 MDR-TB 治疗的 15 至 49 岁女性患者的生活经历。本研究采用目的取样法,对在利拉地区医院接受耐多药结核病治疗的 15 至 49 岁女性患者进行了现象学定性研究。数据收集采用了英译兰戈语深度访谈指南。数据由人工输入,并使用第 13 版定性程序 NVIVO 进行分析。研究发现,女性 MDR-TB 患者的配偶缺乏社会支持。在感染 MDR-TB 之前有结核病史的女性患者有
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信